Irinotecan (CPT-11)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Irinotecan (CPT-11), covering 2014-07-23 to 2026-04-17. Get the full timeline:
Most recent: Clinical Trial Update: Irinotecan and Temozolomide in Combination With Existing High Dose Alkylator Based Chemotherapy for Treatment of Patients With Newly Diagnosed Ewing Sarcoma [Phase 2]